Marker Therapeutics (MRKR) Net Margin (2017 - 2025)
Marker Therapeutics' Net Margin came in at -154.35% for Q4 2025, up 16.07 percentage points from -170.43% a year earlier and up 7.75 percentage points from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Net Margin (2017 - 2025) Analysis & Trends
For FY2025, Marker Therapeutics' Net Margin was -342.96%, down 180.14 percentage points from FY2024.
- Net Margin carries a five-year change of +5398.26 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -162.82% in FY2024 (+85.95 pp), -248.76% in FY2023 (+603.11 pp), -851.87% in FY2022 (+2520.81 pp) and -3372.68% in FY2021 (+2368.54 pp).
- The Q4 2025 figure represents the highest quarterly Net Margin since Q3 2024.
- Year-over-year, Net Margin increased in four of the last seven quarters, with an average year-over-year change of -35.32 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q3 2024 (a gain of 1037.72 percentage points), and the weakest in Q1 2025 (a drop of 1081.26 percentage points).
- Business Quant data shows MRKR's Net Margin at -162.11% (Q3 2025), -466.28% (Q2 2025) and -1273.60% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -154.35% |
| Sep 30, 2025 | -162.11% |
| Jun 30, 2025 | -466.28% |
| Mar 31, 2025 | -1,273.60% |
| Dec 31, 2024 | -170.43% |
| Sep 30, 2024 | -119.84% |
| Jun 30, 2024 | -187.53% |
| Mar 31, 2024 | -192.34% |
| Dec 31, 2023 | -265.31% |
| Sep 30, 2023 | -1,157.57% |
| Dec 31, 2022 | -508.00% |
| Sep 30, 2022 | -692.26% |
| Jun 30, 2022 | -1,169.40% |
| Mar 31, 2022 | -1,027.72% |
| Dec 31, 2020 | -25,612.61% |
| Jun 30, 2020 | -1,358.59% |
| Dec 31, 2019 | -2,382.41% |
| Jun 30, 2018 | -2,336.38% |
| Sep 30, 2017 | -2,177.11% |
API Access
Marker Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();